TD Private Client Wealth LLC Buys 4,392 Shares of DaVita Inc. (NYSE:DVA)

TD Private Client Wealth LLC raised its position in shares of DaVita Inc. (NYSE:DVA) by 1,483.8% during the 4th quarter, HoldingsChannel.com reports. The fund owned 4,688 shares of the company’s stock after acquiring an additional 4,392 shares during the period. TD Private Client Wealth LLC’s holdings in DaVita were worth $701,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. SBI Securities Co. Ltd. bought a new stake in shares of DaVita during the fourth quarter valued at approximately $41,000. Quarry LP bought a new position in shares of DaVita in the 3rd quarter worth about $60,000. Venturi Wealth Management LLC lifted its position in DaVita by 59.8% during the 4th quarter. Venturi Wealth Management LLC now owns 406 shares of the company’s stock valued at $61,000 after acquiring an additional 152 shares during the period. Versant Capital Management Inc boosted its stake in DaVita by 58.7% during the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock worth $68,000 after acquiring an additional 169 shares in the last quarter. Finally, Blue Trust Inc. grew its holdings in DaVita by 39.7% in the fourth quarter. Blue Trust Inc. now owns 461 shares of the company’s stock worth $76,000 after purchasing an additional 131 shares during the period. Institutional investors own 90.12% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on DVA. Sanford C. Bernstein set a $184.00 target price on shares of DaVita in a research note on Friday, February 21st. Barclays boosted their target price on DaVita from $164.00 to $169.00 and gave the stock an “equal weight” rating in a report on Tuesday, February 18th. StockNews.com downgraded DaVita from a “buy” rating to a “hold” rating in a report on Friday. Finally, Cowen reiterated a “hold” rating on shares of DaVita in a research note on Tuesday, February 18th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $166.33.

DaVita Trading Down 0.5 %

DaVita stock opened at $148.25 on Monday. DaVita Inc. has a one year low of $125.64 and a one year high of $179.60. The business’s fifty day moving average is $158.53 and its 200 day moving average is $157.56. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.26 and a quick ratio of 1.21. The stock has a market capitalization of $11.86 billion, a PE ratio of 13.80, a price-to-earnings-growth ratio of 1.07 and a beta of 0.99.

DaVita (NYSE:DVA) last announced its quarterly earnings results on Thursday, February 13th. The company reported $2.24 EPS for the quarter, topping analysts’ consensus estimates of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. On average, sell-side analysts predict that DaVita Inc. will post 10.76 EPS for the current year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.